AsOf

Recorded or changed on this day 2026-11-08

2,201–2,250 of 46,540 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 77,626,000,000 United States dollar
Amgen total assets: 77,626,000,000 United States dollar, claim clm_7C10FDC2C635 · ended · superseded by clm_A52F1A8099CB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,071,000,000 United States dollar
Amgen quarterly net income: 2,071,000,000 United States dollar, claim clm_7D03D58A08B9 · ended · superseded by clm_2970793B064E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 70,775,000,000 United States dollar
Amgen total assets: 70,775,000,000 United States dollar, claim clm_7D37893DF373 · ended · superseded by clm_554D2AE9FD76 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 5,081,000,000 United States dollar
Amgen net income: 5,081,000,000 United States dollar, claim clm_7D7780676598 · ended · superseded by clm_071C52720059 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 736,452,791 shares
Amgen shares outstanding: 736,452,791 shares, claim clm_7DBD3E835AB8 · ended · superseded by clm_64EE6A24BD4B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 754,327,866 shares
Amgen shares outstanding: 754,327,866 shares, claim clm_7E3142F8191A · ended · superseded by clm_9623B7B662B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,476,000,000 United States dollar
Amgen quarterly operating income: 2,476,000,000 United States dollar, claim clm_7E3BD1C19435 · ended · superseded by clm_BEF30CEEC59D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 533,976,238 shares
Amgen shares outstanding: 533,976,238 shares, claim clm_7EB6F1E516E7 · ended · superseded by clm_69A1D6DBF618 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,238,000,000 United States dollar
Amgen quarterly revenue: 6,238,000,000 United States dollar, claim clm_7ED75B6E7D04 · ended · superseded by clm_8C035E8371E9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 8,394,000,000 United States dollar
Amgen net income: 8,394,000,000 United States dollar, claim clm_7F963F7A3BF5 · ended · superseded by clm_43A49B7648F8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 746,000,000 United States dollar
Amgen quarterly net income: 746,000,000 United States dollar, claim clm_7FB87156E0B7 · ended · superseded by clm_3554CF74631E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 536,434,692 shares
Amgen shares outstanding: 536,434,692 shares, claim clm_7FEA7977C094 · ended · superseded by clm_17A7DEA15E83 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 6,191,000,000 United States dollar
Amgen operating income: 6,191,000,000 United States dollar, claim clm_7FEB7D7DF8E7 · ended · superseded by clm_5F24CA9F1236 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 906,000,000 United States dollar
Amgen quarterly net income: 906,000,000 United States dollar, claim clm_8016AE1D57BE · ended · superseded by clm_83CFCB7D01DA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 1,712,000,000 United States dollar
Amgen cash and equivalents: 1,712,000,000 United States dollar, claim clm_8100A4FAF341 · ended · superseded by clm_7B2497997F4E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 3,980,000,000 United States dollar
Amgen operating income: 3,980,000,000 United States dollar, claim clm_812C4678103A · ended · superseded by clm_3327385ED8BC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 791,432,134 shares
Amgen shares outstanding: 791,432,134 shares, claim clm_814F8DBF99DF · ended · superseded by clm_70560450A8A4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 71,209,000,000 United States dollar
Amgen total assets: 71,209,000,000 United States dollar, claim clm_821821A36787 · ended · superseded by clm_397DCD0B0485 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 1,266,000,000 United States dollar
Amgen cash and equivalents: 1,266,000,000 United States dollar, claim clm_8218A755F248 · ended · superseded by clm_13EE0E401521 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,547,000,000 United States dollar
Amgen quarterly net income: 1,547,000,000 United States dollar, claim clm_82CA77D552C0 · ended · superseded by clm_A1443987DC93 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 1,015,476,612 shares
Amgen shares outstanding: 1,015,476,612 shares, claim clm_83B59A7440D5 · ended · superseded by clm_A4143E50C193 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,121,000,000 United States dollar
Amgen quarterly net income: 1,121,000,000 United States dollar, claim clm_83CFCB7D01DA · ended · superseded by clm_928390BED923 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 36,427,000,000 United States dollar
Amgen total assets: 36,427,000,000 United States dollar, claim clm_84388ADC01D3 · ended · superseded by clm_8A50591E1758 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 4,345,000,000 United States dollar
Amgen net income: 4,345,000,000 United States dollar, claim clm_84C2CE669D18 · ended · superseded by clm_7D7780676598 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 12,500,000,000 United States dollar
Amgen total equity: 12,500,000,000 United States dollar, claim clm_84D402BD4390 · ended · superseded by clm_B43E99166EDA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,442,000,000 United States dollar
Amgen quarterly operating income: 1,442,000,000 United States dollar, claim clm_84DD01B3B35F · ended · superseded by clm_1DF1A1C609E1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 9,708,000,000 United States dollar
Amgen cash and equivalents: 9,708,000,000 United States dollar, claim clm_85A3377148F1 · ended · superseded by clm_7A6976D86AF0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,723,000,000 United States dollar
Amgen quarterly revenue: 5,723,000,000 United States dollar, claim clm_85E7DB9BD8C5 · ended · superseded by clm_9742AA3344DF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,687,000,000 United States dollar
Amgen cash and equivalents: 3,687,000,000 United States dollar, claim clm_85F128FF8BDF · ended · superseded by clm_DA248B5305A9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 537,532,723 shares
Amgen shares outstanding: 537,532,723 shares, claim clm_8727DF5F4982 · ended · superseded by clm_3BD301427B1F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,921,000,000 United States dollar
Amgen quarterly operating income: 1,921,000,000 United States dollar, claim clm_87A3CD3A03BE · ended · superseded by clm_5A3FD4672B1E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,904,000,000 United States dollar
Amgen quarterly revenue: 5,904,000,000 United States dollar, claim clm_87A5042FAB0D · ended · superseded by clm_9AD858C121AE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,629,000,000 United States dollar
Amgen cash and equivalents: 2,629,000,000 United States dollar, claim clm_88AF69313798 · ended · superseded by clm_0BA540E04C08 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,258,000,000 United States dollar
Amgen quarterly net income: 1,258,000,000 United States dollar, claim clm_890A9BB01DD3 · ended · superseded by clm_BF2B62C3B6C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 13,989,000,000 United States dollar
Amgen cash and equivalents: 13,989,000,000 United States dollar, claim clm_89D0D620B239 · ended · superseded by clm_682A30955369 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,605,000,000 United States dollar
Amgen quarterly operating income: 1,605,000,000 United States dollar, claim clm_8A1A7F8B1FAB · ended · superseded by clm_AD3F260E35C2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,434,000,000 United States dollar
Amgen quarterly net income: 1,434,000,000 United States dollar, claim clm_8A4D481B9F27 · ended · superseded by clm_890A9BB01DD3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 38,840,000,000 United States dollar
Amgen total assets: 38,840,000,000 United States dollar, claim clm_8A50591E1758 · ended · superseded by clm_960D1E6B27F0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 14,909,000,000 United States dollar
Amgen total equity: 14,909,000,000 United States dollar, claim clm_8A7A5177FE47 · ended · superseded by clm_08B4799386AF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 759,607,230 shares
Amgen shares outstanding: 759,607,230 shares, claim clm_8A83A0002048 · ended · superseded by clm_93F41910F022 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 24,984,000,000 United States dollar
Amgen total equity: 24,984,000,000 United States dollar, claim clm_8B2C132F4605 · ended · superseded by clm_67DA709539BB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 18,512,000,000 United States dollar
Amgen total equity: 18,512,000,000 United States dollar, claim clm_8B4D216D886A · ended · superseded by clm_AF67FFE7C117 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,594,000,000 United States dollar
Amgen quarterly revenue: 6,594,000,000 United States dollar, claim clm_8C035E8371E9 · ended · superseded by clm_5A9AC839EF5A · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · CEO · Robert A. Bradway
Amgen CEO: Robert A. Bradway, claim clm_8C06E7ECEEE2 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,810,000,000 United States dollar
Amgen quarterly revenue: 5,810,000,000 United States dollar, claim clm_8C784DFC08A6 · ended · superseded by clm_3BAD99E25427 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,107,000,000 United States dollar
Amgen quarterly net income: 1,107,000,000 United States dollar, claim clm_8CA0968C8B53 · ended · superseded by clm_8A4D481B9F27 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 9,485,000,000 United States dollar
Amgen total equity: 9,485,000,000 United States dollar, claim clm_8CEE5F0631D9 · ended · superseded by clm_A29CDA8096D2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 90,534,000,000 United States dollar
Amgen total assets: 90,534,000,000 United States dollar, claim clm_8D2BB66829A3 · ended · superseded by clm_28FA2561E047 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · total assets · 96,048,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,112,000,000 United States dollar
Amgen cash and equivalents: 6,112,000,000 United States dollar, claim clm_8D9D5DB7A5DE · ended · superseded by clm_EE459468FEEE · 1 source (1 primary) · conf 0.95

What the statuses mean